225 related articles for article (PubMed ID: 38071654)
21. Barriers to Clinical Trial Implementation Among Community Care Centers.
Ebrahimi H; Megally S; Plotkin E; Shivakumar L; Salgia NJ; Zengin ZB; Meza L; Chawla N; Castro DV; Dizman N; Bhagat R; Liv S; Li X; Rock A; Liu S; Tripathi A; Dorff T; Oyer RA; Boehmer L; Pal S; Chehrazi-Raffle A
JAMA Netw Open; 2024 Apr; 7(4):e248739. PubMed ID: 38683608
[TBL] [Abstract][Full Text] [Related]
22. Barriers and facilitators of clinical trial enrollment in a network of community-based pediatric oncology clinics.
Russo C; Stout L; House T; Santana VM
Pediatr Blood Cancer; 2020 Apr; 67(4):e28023. PubMed ID: 31556250
[TBL] [Abstract][Full Text] [Related]
23. Strategies to Advance Equity in Cancer Clinical Trials.
Guerra CE; Fleury ME; Byatt LP; Lian T; Pierce L
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-11. PubMed ID: 35687825
[TBL] [Abstract][Full Text] [Related]
24. Real-world Application of Racial and Ethnic Imputation and Cohort Balancing Techniques to Deliver Equitable Clinical Trial Recruitment.
Craig KJ; Ji YJ; Zhang YC; Berk A; Zaleski A; Abdelsamad O; Coetzer H; Verbrugge DJ; Hua G
AMIA Annu Symp Proc; 2023; 2023():319-328. PubMed ID: 38222354
[TBL] [Abstract][Full Text] [Related]
25. Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
Andrasik MP; Broder GB; Wallace SE; Chaturvedi R; Michael NL; Bock S; Beyrer C; Oseso L; Aina J; Lucas J; Wilson DR; Kublin JG; Mensah GA
PLoS One; 2021; 16(10):e0258858. PubMed ID: 34665829
[TBL] [Abstract][Full Text] [Related]
26. Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.
Winestone LE; Beauchemin MP; Bona K; Kahn J; Prasad P; Robles JM; Velez MC;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30592. PubMed ID: 37501542
[TBL] [Abstract][Full Text] [Related]
27. Increasing Inclusiveness of Patient-Centric Clinical Evidence Generation in Oncology: Real-World Data and Clinical Trials.
Benbow JH; Rivera DR; Lund JL; Feldman JE; Kim ES
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-11. PubMed ID: 35561304
[TBL] [Abstract][Full Text] [Related]
28. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
[TBL] [Abstract][Full Text] [Related]
29. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
30. Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory.
DeFilippis EM; Echols M; Adamson PB; Batchelor WB; Cooper LB; Cooper LS; Desvigne-Nickens P; George RT; Ibrahim NE; Jessup M; Kitzman DW; Leifer ES; Mendoza M; Piña IL; Psotka M; Senatore FF; Stein KM; Teerlink JR; Yancy CW; Lindenfeld J; Fiuzat M; O'Connor CM; Vardeny O; Vaduganathan M
JAMA Cardiol; 2022 May; 7(5):540-548. PubMed ID: 35319725
[TBL] [Abstract][Full Text] [Related]
31. Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot.
Matthew-Onabanjo AN; Nortey G; Matulewicz RS; Basak R; Culton DA; Weaver KN; Gallagher KK; Tan HJ; Rose TL; Milowsky M; Bjurlin MA
Curr Probl Cancer; 2023 Jun; 47(3):100958. PubMed ID: 37084464
[TBL] [Abstract][Full Text] [Related]
32. Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.
Pittell H; Calip GS; Pierre A; Ryals CA; Altomare I; Royce TJ; Guadamuz JS
JAMA Netw Open; 2023 Jul; 6(7):e2322515. PubMed ID: 37477920
[TBL] [Abstract][Full Text] [Related]
33. Equitable Representation of Latinos in Clinical Research Is Needed to Achieve Health Equity in Cancer Care.
Ramirez AG; Chalela P
JCO Oncol Pract; 2022 May; 18(5):e797-e804. PubMed ID: 35544655
[TBL] [Abstract][Full Text] [Related]
34. Demographic reporting and language exclusion in gynecologic oncology clinical trials.
Lee SS; Dinicu AI; Arthurs L; Shields D; Pothuri B; Lightfoot MDS
Am J Obstet Gynecol; 2024 Jan; 230(1):73.e1-73.e14. PubMed ID: 37751830
[TBL] [Abstract][Full Text] [Related]
35. Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020.
Walker DM; Swoboda CM; Shiu-Yee K; Tarver WL; Nolan TS; Joseph JJ
J Gen Intern Med; 2023 Mar; 38(4):961-969. PubMed ID: 36138277
[TBL] [Abstract][Full Text] [Related]
36. Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
Jorge S; Masshoor S; Gray HJ; Swisher EM; Doll KM
J Natl Compr Canc Netw; 2023 Jan; 21(1):27-32.e2. PubMed ID: 36634612
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials.
Stewart J; Krows ML; Schaafsma TT; Heller KB; Brown ER; Boonyaratanakornkit J; Brown CE; Leingang H; Liou C; Bershteyn A; Schwartz MD; Agrawal V; Friedman-Klabanoff D; Eustace S; Stankiewicz Karita HC; Paasche-Orlow MK; Kissinger P; Hosek SG; Chu HY; Celum C; Baeten JM; Wald A; Johnston C; Barnabas RV
JAMA Netw Open; 2022 Feb; 5(2):e2148325. PubMed ID: 35157053
[TBL] [Abstract][Full Text] [Related]
38. A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access.
Mohan SV; Freedman J
Clin Pharmacol Ther; 2023 Mar; 113(3):518-527. PubMed ID: 36536992
[TBL] [Abstract][Full Text] [Related]
39. Barriers to diverse clinical trial participation in Duchenne muscular dystrophy: Engaging Hispanic/Latina caregivers and health professionals.
Crossnohere NL; Campoamor NB; Camino E; Dresnick E; Martschenko DO; Rodrigues V; Apkon S; Hazlett A; Mittur D; Rodriguez PE; Bridges JFP; Armstrong N
Orphanet J Rare Dis; 2024 May; 19(1):207. PubMed ID: 38773664
[TBL] [Abstract][Full Text] [Related]
40. Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review.
Fakhry JS; Pena MJ; Pomputius A; Giap F; Vega RBM
Int J Part Ther; 2023; 10(1):51-58. PubMed ID: 37823018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
